NCT06572800 - Tka Assay for CDK4/6i | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 5, 2023

Primary Completion Date

September 16, 2025

Study Completion Date

September 16, 2025

Conditions

Anatomic Stage IV Breast Cancer AJCC v8Metastatic HER2-Negative Breast Carcinoma

Interventions

DEVICE

DiviTum-TKa

Analyze blood samples by DiviTum-TKa

Trial Locations (18)

06418

Smilow Cancer Hospital-Derby Care Center, Derby

06824

Smilow Cancer Hospital Care Center-Fairfield, Fairfield

06033

Smilow Cancer Hospital Care Center at Glastonbury, Glastonbury

06830

Smilow Cancer Hospital Care Center at Greenwich, Greenwich

06437

Smilow Cancer Hospital Care Center - Guilford, Guilford

06518

Smilow Cancer Hospital-Hamden Care Center, Hamden

06105

Smilow Cancer Hospital Care Center at Saint Francis, Hartford

06510

Smilow Cancer Center/Yale-New Haven Hospital, New Haven

06511

Yale-New Haven Hospital Saint Raphael Campus, New Haven

06520

Yale University, New Haven

06473

Yale-New Haven Hospital North Haven Medical Center, North Haven

06477

Smilow Cancer Hospital-Orange Care Center, Orange

06902

Smilow Cancer Hospital Care Center at Long Ridge, Stamford

06790

Smilow Cancer Hospital-Torrington Care Center, Torrington

06611

Smilow Cancer Hospital Care Center-Trumbull, Trumbull

06708

Smilow Cancer Hospital-Waterbury Care Center, Waterbury

06385

Smilow Cancer Hospital Care Center - Waterford, Waterford

02891

Smilow Cancer Hospital Care Center - Westerly, Westerly

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Yale University

OTHER